The Swiss Competition Authority carries out a dawn raid which causes a pharmaceutical company to drop IP infringement court actions against competitor (Novartis / Lily)

As we have previously reported (Van Bael & Bellis Life Sciences News and Insights, 15 September 2022), on 13 September 2022, the Swiss Competition Authority carried out an inspection at the premises of Novartis Pharma AG ( Novartis ). In parallel, Novartis received a request for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)

Quotation

Giovanni Pregno, Catherine Longeval, Peter L'Ecluse, Koen T'Syen, The Swiss Competition Authority carries out a dawn raid which causes a pharmaceutical company to drop IP infringement court actions against competitor (Novartis / Lily), 15 September 2022, e-Competitions November 2022 - II, Art. N° 109532

Visites 145

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues